Moderna（MRNA）股价今日盘中出现大幅下跌，跌幅达5.05%，引起了投资者的广泛关注。
消息面上，此次股价波动与公司高层人事变动直接相关。Moderna公司宣布，其首席医疗官（CMO）杰奎琳·米勒（Jacqueline Miller）将于3月2日卸任。米勒曾领导公司关键的新冠疫苗Spikevax的开发工作，她的离职正值公司寻求填补COVID产品需求减弱带来的收入缺口、并推动mRNA平台向更广泛领域转型的关键时期。市场分析认为，这一核心研发领导者的变动，引发了投资者对公司未来研发管线推进与业务稳定性的担忧。
根据公司公告，米勒卸任后将继续担任顾问以协助过渡，同时公司已任命大卫·伯曼（David Berman）为首席开发官。尽管如此，市场对此重大人事调整的反应依然消极，导致了股价在交易时段内承压下行。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.